Immunopathogenesis of celiac disease

Inmunologia

Volumn 24, Issue 3, 2005, Pages 313-325

  León, Francisco ^a   Sanchez L ^c   Camarero, C ^b,c   Roy, G ^c  

^a BRISTOL MYERS SQUIBB   (United States)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Autoimmunity; Celiac; Gluten; IEL; Transglutaminase

Indexed keywords

HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROLAMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ABSORPTIOMETRY; CELIAC DISEASE; DIET; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LYMPHOCYTE; REVIEW;

EID: 29444442267     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (180)

1. Gee SJ. On the coeliac affection. St. Bartholomew's Hospital Reports 1888;17-20.
2. Dicke WK, Weijers HA, Van De Kamer JH. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr 1953;42:34-42.
3. Royer M, Croxatto O, Biempica L, Balcazar Morrison AJ. [Duodenal biopsy by aspiration under radioscopic control]. Prensa Med Argent 1955;42:2515-2519.
4. Crosby WH, Kugler HW. Intraluminal biopsy of the small intestine; the intestinal biopsy capsule. Am J Dig Dis 1957;2:236-241.
5. Sakula J, Shiner M. Coeliac disease with atrophy of the small-intestine mucosa. Lancet 1957;273:876-877.
6. Chorzelski TP, Beutner EH, Sulej J, Tchorzewska H, Jablonska S, Kumar V, et al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984;111:395-402.
7. Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994;343:200-203.
8. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-350.
9. Spencer J, Isaacson PG, Diss TC, MacDonald TT. Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor gamma/delta heterodimer in human intestinal intraepithelial lymphocytes. Eur J Immunol. 1989;19:1335-1338.
10. Bruce SE, Bjarnason I, Peters TJ. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci (Lond) 1985;68:573-579.
11. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
12. Molberg O, Kett K, Scott H, Thorsby E, Sollid LM, Lundin KE. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 1997;46:103-109.
13. Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, et al. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol 2001;31:1317-1323.
14. Gjertsen HA, Lundin KE, Sollid LM, Eriksen JA, Thorsby E. T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol 1994;39:243-252.
15. Shidrawi RG, Day P, Przemioslo R, Ellis HJ, Nelufer JM, Ciclitira PJ. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol 1995;30:758-763.
16. Lundin KE, Sollid LM, Anthonsen D, Noren O, Molberg O, Thorsby E, et al. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology 1997;112:752-759.
17. van de WY, Kooy YM, van Veelen PA, Pena SA, Mearin LM, Molberg O, et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 1998;95:10050-10054.
18. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297:2275-2279.
19. Mowat AM. Coeliac disease-a meeting point for genetics, immunology, and protein chemistry. Lancet 2003;361:1290-1292.
20. Walker-Smith JA. Celiac Disease. Walker, Durie, Hamilton, Walker-Smith, Watkins. Pediatric Gastrointestinal Disease. Pathophysiology, Diagnosis, Management. Ontario: BC Decker Inc; 2000.
21. Ciclitira PJ, King AL, Fraser JS. AGA technical review on Celiac Sprue. American Gastroenterological Association. Gastroenterology 2001;120:1526-1540.
22. Fasano A. Celiac disease: the past, the present, the future. Pediatrics 2001;107:768-770.
23. Jennings JS; Howdle PD. Celiac disease. Curr Opin Gastroenterol 2001;17:118-126.
24. Maki M; Collin P. Coeliac disease. Lancet 1997;349:1755-1759.
25. Janatuinen EK, Kemppainen TA, Julkunen RJ, Kosma VM, Maki M, Heikkinen M, et al. No harm from five year ingestion of oats in coeliac disease. Gut 2002;50:332-335.
26. Barry RE, Baker P, Read AE. Coeliac disease. The clinical presentation. Clin Gastroenterol 1974;3:55-69.
27. Howdle PD. Coeliac Disease in adults. Marsh MN. Coeliac Disease. Oxford: Blackwell Scientific Publications 1992;49-80.
28. Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: case finding study. BMJ 1999;318:164-167.
29. Weile B, Cavell B, Nivenius K, Krasilnikoff PA. Striking differences in the incidence of childhood celiac disease between Denmark and Sweden: a plausible explanation. J Pediatr Gastroenterol Nutr 1995;21:64-68.
30. Catassi C, Fabiani E, Ratsch IM, Coppa GV, Giorgi PL, Pierdomenico R, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr (Suppl) 1996;412:29-35.
31. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet 1999;353:813-814.
32. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998;33:494-498.
33. Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, Chanoine JP, et al. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol 2001;15:297-301.
34. Ferguson A, Arranz E, O'Mahony S. Clinical and pathological spectrum of coeliac disease-active, silent, latent, potential. Gut 1993;34:150-151.
35. Catassi C, Ratsch IM, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, et al. Why is coeliac disease endemic in the people of the Sahara? Lancet 1999;354:647-648.
36. Gandolfi L, Pratesi R, Cordoba JC, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol 2000;95:689-692.
37. Sher KS, Fraser RC, Wicks AC, Mayberry JF. High risk of coeliac disease in Punjabis. Epidemiological study in the south Asian and European populations of Leicestershire. Digestion 1993;54:178-182.
38. Ascher H, Holm K, Kristiansson B, Maki M. Different features of coeliac disease in two neighbouring countries. Arch Dis Child 1993;69:375-380.
39. Kolho KL, Farkkila MA, Savilahti E. Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol 1998;33:1280-1283.
40. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo S J, et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000;12:495-503.
41. Bottaro G, Failla P, Rotolo N, Sanfilippo G, Azzaro F, Spina M, et al. Changes in coeliac disease behaviour over the years. Acta Paediatr 1993;82:566-568.
42. Hovdenak N, Hovlid E, Aksnes L, Huge G, Erichsen MM, Eide J. High prevalence of asymptomatic coeliac disease in Norway: a study of blood donors. Eur J Gastroenterol Hepatol 1999;11:185-187.
43. Trevisiol C, Not T, Berti I, Buratti E, Citta A, Neri E, et al. Screening for coeliac disease in healthy blood donors at two immunotransfusion centres in north-east Italy. Ital J Gastroenterol Hepatol 1999;31:584-586.
44. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003;348:2517-2524.
45. Walker-Smith JA. Celiac disease and Down syndrome. J Pediatr 2000;137:743-744.
46. Zubillaga P, Vitoria JC, Arrieta A, Echaniz P, Garcia-Masdevall MD. Down's syndrome and celiac disease. J Pediatr Gastroenterol Nutr 1993;16:168-171.
47. Hansson T, Anneren G, Sjoberg O, Klareskog L, Dannaeus A. Celiac disease in relation to immunologic serum markers, trace elements, and HLA-DR and DQ antigens in Swedish children with Down syndrome. J Pediatr Gastroenterol Nutr 1999;29:286-292.
48. Mawhinney H, Tomkin GH. Gluten enteropathy associated with selective IgA deficiency. Lancet 1971;2:121-124.
49. Vitoria JC, Arrieta A, Astigarraga I, Garcia-Masdevall D, Rodriguez-Soriano J. Use of serological markers as a screening test in family members of patients with celiac disease. J Pediatr Gastroenterol Nutr 1994;19:304-309.
50. Maki M, Hallstrom O, Vesikari T, Visakorpi JK. Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease. J Pediatr 1984;105:901-905.
51. Volta U, Lenzi M, Lazzari R, Cassani F, Collina A, Bianchi FB, et al. Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut 1985;26:667-671.
52. Chan KN, Phillips AD, Mirakian R, Walker-Smith JA. Endomysial antibody screening in children. J Pediatr Gastroenterol Nutr 1994;18:316-320.
53. Grodzinsky E, Jansson G, Skogh T, Stenhammar L, Falth-Magnusson K. Anti-endomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine. Acta Paediatr 1995;84:294-298.
54. Vogelsang H, Genser D, Wyatt J, Lochs H, Ferenci P, Granditsch G, et al. Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol 1995;90:394-398.
55. Hansson T, Dannaeus A, Kraaz W, Sjoberg O, Klareskog L. Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for screening and follow-up. Pediatr Res 1997;41:554-559.
56. Roldan MB, Barrio R, Roy G, Parra C, Alonso M, Yturriaga R, et al. Diagnostic value of serological markers for celiac disease in diabetic children and adolescents. J Pediatr Endocrinol Metab 1998;11:751-756.
57. Guix M, Skinner JM, Whitehead R. Measuring intraepithelial lymphocytes, surface area, and volume of lamina propria in the jejunal mucosa of coeliac patients. Gut 1979;20:275-278.
58. Marsh MN. Studies of intestinal lymphoid tissue. III. Quantitative analyses of epithelial lymphocytes in the small intestine of human control subjects and of patients with celiac sprue. Gastroenterology 1980;79:481-492.
59. Butterworth CE Jr, Pérez-Santiago E. Jejunal biopsies in sprue. Ann Intern Med 1958;48:8-29.
60. MacDonald TT, Bajaj-Elliott M, Pender SL. T cells orchestrate intestinal mucosal shape and integrity. Immunol Today 1999;20:505-510.
61. Chan KN, Phillips AD, Walker-Smith JA, Koskimies S, Spencer J. Density of gamma/delta T cells in small bowel mucosa related to HLA-DQ status without coeliac disease. Lancet 1993;342:492-493.
62. Manuel PD, Walker-Smith JA, France NE. Patchy enteropathy in childhood. Gut 1979;20:211-215.
63. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch. Dis Child 1990;65:909-911.
64. Faulkner-Hogg KB, Selby WS, Loblay RH. Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: the role of trace amounts of gluten and non-gluten food intolerances. Scand J Gastroenterol 1999;34:784-789.
65. Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000;356:203-208.
66. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000;119:243-251.
67. Ventura A, Magazu G, Gerarduzzi T, Greco L. Coeliac disease and the risk of autoimmune disorders. Gut 2002;51:897-898.
68. Martinelli P, Troncone R, Paparo F, Torre P, Trapanese E, Fasano C, et al. Coeliac disease and unfavourable outcome of pregnancy. Gut 2000;46:332-335.
69. Ludvigsson JF, Ludvigsson J. Coeliac disease in the father affects the newborn. Gut 2001;49:169-175.
70. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989;30:333-338.
71. Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell. Scand J Gastroenterol 2000;35:785-790.
72. Schweizer JJ, Oren A, Mearin ML. Cancer in children with celiac disease: a survey of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2001;33:97-100.
73. Barbeau WE, Novascone MA, Elgert KD. Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? Mol Immunol 1997;34:535-541.
74. Godkin A, Jewell D. The pathogenesis of celiac disease. Gastroenterology 1998;115:206-210.
75. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-242.
76. Kagnoff MF, Paterson YJ, Kumar PJ, Kasarda DD, Carbone FR, Unsworth DJ, et al. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987;28:995-1001.
77. Lahdeaho ML, Parkkonen P, Reunala T, Maki M, Lehtinen M. Antibodies to E1b protein-derived peptides of enteric adenovirus type 40 are associated with celiac disease and dermatitis herpetiformis. Clin Immunol Immunopathol 1993;69:300-305.
78. Marsh MN. Immunocytes, enterocytes and the lamina propria: an immunopathological framework of coeliac disease. J. R. Coll. Physicians Lond 1983;17:205-212.
79. Ferguson A, MacDonald TT, McClure JP, Holden RJ. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet 1975;1:895-897.
80. Green PH, Jabri B. Coeliac disease. Lancet 2003;362:383-391.
81. King AL, Ciclitira PJ. Celiac disease: strongly heritable, oligogenic, but genetically complex. Mol Genet Metab 2000;71:70-75.
82. Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, et al. The first large population based twin study of coeliac disease. Gut 2002;50:624-628.
83. Spurkland A, Sollid LM, Polanco I, Vartdal F, Thorsby E. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 1992;35:188-192.
84. Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 1992;40:90-97.
85. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993;105:910-922.
86. Fernandez-Arquero M, Polanco I, Escobar H, Figueredo MA, de la Concha EG, Clerici-Larradet N. HLA-DQ alleles and susceptibility to celiac disease in Spanish children. Tissue Antigens 1995;45:145-147.
87. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997;49:29-34.
88. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998;43:187-189.
89. King AL, Moodie SJ, Fraser JS, Curtis D, Reid E, Dearlove AM, et al. CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families. J Med Genet 2002;39:51-54.
90. Popat S, Hearle N, Hogberg L, Braegger CP, O'Donoghue D, Falth-Magnusson K, et al. Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. Ann Hum Genet 2002;66:125-137.
91. Greco L, Corazza G, Babron MC, Clot F, Fulchignoni-Lataud MC, Percopo S, et al. Genome search in celiac disease. Am. J Hum Genet 1998;62:669-675.
92. Greco L, Babron MC, Corazza GR, Percopo S, Sica R, Clot F, et al. Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet 2001;65:35-41.
93. Liu J, Juo SH, Holopainen P, Terwilliger J, Tong X, Grunn A, et al. Genomewide linkage analysis of celiac disease in Finnish families. Am J Hum Genet 2002;70:51-59.
94. Van De Kamer JH, Weijers HA, Dicke WK. Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr 1953;42:223-231.
95. Kagnoff MF. Celiac disease. Yamada T. Testbook of Gastroenterology. Philadelphia, Lippincott 1995;1643-1661.
96. Cornell H, Wieser H, Belitz HD. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease. Clin Chim Acta 1992;213:37-50.
97. Wieser H. The precipitating factor in coeliac disease. Baillieres Clin. Gastroenterol 1995;9:191-207.
98. Molberg O, Solheim FN, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, et al. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 2003;125:337-344.
99. Wieser H. Chemistry of gliadins. Eur J Gastroenterol Hepatol 1991;3:102-107.
100. Howdle PD, Ciditira PJ, Simpson FG, Losowsky MS. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins. Scand J Gastroenterol 1984;19:41-47.
101. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-354.
102. Ciclitira PJ, Evans DJ, Fagg NL, Lennox ES, Dowling RH. Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) 1984; 66:357-364.
103. Fais S, Maiuri L, Pallone F, De Vincenzi M, De Ritis G, Troncone R, et al. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa. Gut 1992;33:472-475.
104. Maiuri L, Picarelli A, Boirivant M, Coletta S, Mazzilli MC, De Vincenzi M, et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996;110:1368-1378.
105. Friis S, Dabelsteen E, Sjostrom H, Noren O, Jarnum S. Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals. Gut 1992;33:1487-1492.
106. Clemente MG, Musu MP, Frau F, Brusco G, Sole G, Corazza GR, et al. Immune reaction against the cytoskeleton in coeliac disease. Gut 2000;47:520-526.
107. Klein JR, Hamad M. Gamma delta T cells, antigen recognition and intestinal immunity. Immunol Today 1995;16:108-109.
108. Unsworth DJ, Wurzner R, Brown DL, Lachmann PJ. Extracts of wheat gluten activate complement via the alternative pathway. Clin Exp Immunol 1993;94:539-543.
109. Corrao G, Corazza GR, Andreani ML, Torchio P, Valentini RA, Galatola G, et al. Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 1994;35:771-775.
110. Petaros P, Martelossi S, Tommasini A, Torre G, Caradonna M, Ventura A. Prevalence of autoimmune disorders in relatives of patients with celiac disease. Dig Dis Sci 2002;47:1427-1431.
111. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117:297-303.
112. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071-3077.
113. Piacentini M, Colizzi V. Tissue transglutaminase: apoptosis versus autoimmunity. Immunol Today 1999;20:130-134.
114. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 1996;8:177-182.
115. Bartnes K, Leon F, Briand JP, Travers PJ, Hannestad K. A novel first primary anchor extends the MHC class II I-Ad binding motif to encompass nine amino acids. Int Immunol 1997;9:1185-1193.
116. Moustakas AK, van de WY, Routsias J, Kooy YM, van Veelen P, Drijfhout JW, et al. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int Immunol 2000;12:1157-1166.
117. van de WY, Kooy YM, Drijfhout JW, Amons R, Koning F. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics 1996;44:246-253.
118. Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713-717.
119. van de WY, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585-1588.
120. Uhlig HH, Lichtenfeld J, Osman AA, Richter T, Mothes T. Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase. Eur J Gastroenterol Hepatol 2000;12:1017-1020.
121. Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998;115:1317-1321.
122. León F, Camarero C, Pena R, Eiras P, Sanchez L, Baragaño M, et al. Anti-transglutaminase IgA ELISA: Clinical potential and drawbacks in Celiac Disease diagnosis. Scand J Gastroenterol 2001;36:849-853.
123. Sollid LM, Molberg O, McAdam S, Lundin KE. Autoantibodies in coeliac disease: tissue transglutaminase-guilt by association? Gut 1997;41:851-852.
124. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
125. van de WY, Kooy Y, van Veelen P, Vader W, Koning F, Pena S. Coeliac disease: it takes three to tango! Gut 2000;46:734-737.
126. Marzari R, Sblattero D, Florian F, Tongiorgi E, Not T, Tommasini A, et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 2001;166:4170-4176.
127. Brusco G, Muzi P, Ciccocioppo R, Biagi F, Cifone MG, Corazza GR. Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression. Clin Exp Immunol 1999;118:371-375.
128. Biagi F, Parnell ND, Ellis HJ, Ciclitira PJ. Endomysial antibody production is not related to histological damage after in vitro gluten challenge. Eur J Gastroenterol Hepatol 2000;12:57-60.
129. Maiuri L, Ciacci C, Raia V, Vacca L, Ricciardelli I, Raimondi F, et al. FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut 2001;48:418-424.
130. Halttunen T, Maki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999;116:566-572.
131. Esposito C, Paparo F, Caputo I, Rossi M, Maglio M, Sblattero D, et al. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut 2002;51:177-181.
132. Arentz-Hansen H, Mcadam SN, Molberg O, Fleckenstein B, Lundin KE, Jorgensen TJ, et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002;123:803-809.
133. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 1993;105:1323-1332.
134. Nunes I, Gleizes PE, Metz CN, Rifkin DB. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 1997;136:1151-1163.
135. + T cells and macrophages but no crypt-cell hyperplasia. Scand J Immunol 1993;38:581-590.
136. Eiras P, Roldan E, Camarero C, Olivares F, Bootello A, Roy G. Flow cytometry description of a novel CD3-/CD7+ intraepithelial lymphocyte subset in human duodenal biopsies: potential diagnostic value in coeliac disease. Cytometry 1998;34:95-102.
137. + and T cell receptor gammadelta subsets studied by flow cytometry. Acta Paediatr 2000;89:285-290.
138. Spencer J, MacDonald TT, Diss TC, Walker-Smith JA, Ciclitira PJ, Isaacson PG. Changes in intraepithelial lymphocyte subpopulations in coeliac disease and enteropathy associated T cell lymphoma (malignant histiocytosis of the intestine). Gut 1989;30:339-346.
139. Savilahti E, Arato A, Verkasalo M. Intestinal gamma/delta receptor-bearing T lymphocytes in celiac disease and inflammatory bowel diseases in children. Constant increase in celiac disease. Pediatr Res 1990;28:579-581.
140. Spencer J, Isaacson PG, MacDonald TT, Thomas AJ, Walker-Smith JA. Gamma/delta T cells and the diagnosis of coeliac disease. Clin Exp Immunol 1991;85:109-113.
141. Holm K, Maki M, Savilahti E, Lipsanen V, Laippala P, Koskimies S. Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet 1992;339:1500-1503.
142. + alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium. Eur J Immunol 1993;23:505-510.
143. Kokkonen J, Holm K, Karttunen TJ, Maki M. Children with untreated food allergy express a relative increment in the density of duodenal gammadelta+ T cells. Scand J Gastroenterol 2000;35:1137-1142.
144. Nilssen DE, Halstensen TS, Froland SS, Fausa O, Brandtzaeg P. Distribution and phenotypes of duodenal intraepithelial gamma/delta T cells in patients with various types of primary B-cell deficiency. Clin Immunol Immunopathol 1993;68:301-310.
145. Iltanen S, Rantala I, Laippala P, Holm K, Partanen J, Maki M. Expression of HSP-65 in jejunal epithelial cells in patients clinically suspected of coeliac disease. Autoimmunity 1999;31:125-132.
146. Nilssen DE, Aukrust P, Froland SS, Muller F, Fausa O, Halstensen TS, et al. Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency. Clin Exp Immunol 1993;94:91-98.
147. Trejdosiewicz LK, Calabrese A, Smart CJ, Oakes DJ, Howdle PD, Crabtree JE, et al. Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease. Clin Exp Immunol 1991;84:440-444.
148. + subset expressing natural killer markers and a singular pattern of adhesion molecules. Scand J Immunol 2000;52:1-6.
149. Leon F, Roldan E, Sanchez L, Camarero C, Bootello A, Roy G. Human small-intestinal epithelium contains functional natural killer lymphocytes. Gastroenterology 2003;125:345-356.
150. Sugi K, Musch MW, Field M, Chang EB. Inhibition of Na+,K+-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function. Gastroenterology 2001;120:1393-1403.
151. Nagata S, McKenzie C, Pender SL, Bajaj-Elliott M, Fairclough PD, Walker-Smith JA, et al. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol 2000;165:5315-5321.
152. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-342.
153. Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996;183:237-247.
154. Alpan O, Rudomen G, Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 2001;166:4843-4852.
155. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001;166:4884-4890.
156. Martin-Villa JM, Ferre-Lopez S, Lopez-Suarez JC, Corell A, Perez-Blas M, Arnaiz-Villena A. Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens 1997;50:586-592.
157. Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today 2000;21:123-128.
158. + T cell activation during Helicobacter pylori infection. J Clin Invest 1997;99:1628-1636.
159. Hershberg RM, Cho DH, Youakim A, Bradley MB, Lee JS, Framson PE, et al. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J Clin Invest 1998;102:792-803.
160. Nakazawa A, Watanabe M, Kanai T, Yajima T, Yamazaki M, Ogata H, et al. Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa. Gastroenterology 1999;117:536-545.
161. Arstila T, Arstila TP, Calbo S, Selz F, Malassis-Seris M, Vassalli P, et al. Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph. J Exp Med 2000;191:823-834.
162. Shibahara T, Wilcox JN, Couse T, Madara JL. Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes. Gastroenterology 2001;120:60-70.
163. Bajaj-Elliott M, Poulsom R, Pender SL, Wathen NC, MacDonald TT. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest 1998;102:1473-1480.
164. de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, et al. Celiac disease and TNF promoter polymorphisms. Hum Immunol 2000;61:513-517.
165. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-1590.
166. Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999;44:17-25.
167. Satsangi J, Chapman RW, Haldar N, Donaldson P, Mitchell S, Simmons J, et al. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 2001;121:124-130.
168. Salvati VM, Bajaj-Elliott M, Poulsom R, Mazzarella G, Lundin K E, Nilsen EM, et al. Keratinocyte growth factor and coeliac disease. Gut 2001;49:176-181.
169. Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000;119:996-1006.
170. Moss SF, Attia L, Scholes JV, Walters JR, Holt PR. Increased small intestinal apoptosis in coeliac disease. Gut 1996;39:811-817.
171. Di Sabatino A, Ciccocioppo R, D'Alo S, Parroni R, Millimaggi D, Cifone MG, et al. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease. Gut 2001;49:380-386.
172. + T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope. J Immunol 2003;170:2719-2726.
173. Mention JJ, Ben Ahmed M, Begue B, Barbe U, Verkarre V, Asnafi V, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003;125:730-745.
174. Jabri B, de Serre NP, Cellier C, Evans K, Gache C, Carvalho C, et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000;118:867-879.
175. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004;21:367-377.
176. Meresse B, Chen Z, Ciszewski C, Tretiacova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Green P, Jabri B. Coordinated Induction by IL15 of a TCR-Independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in Celiac Disease. Immunity 2004;21:357-366.
177. Leon F, Roy G. On the complexity of human CD3-Intraepithelial Lymphocytes. Gastroenterology 2004;126:1217-1219.
178. Leon F, Eiras P, Camarero C, Roy G. Intestinal intraepithelial lymphocytes and anti-transglutaminase in a screening algorithm for Coeliac Disease. Gut 2002;50:740-742.
179. Kelsall BL, Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol Rev 2005;206:132-148.
180. León F, Sánchez L, Camarero C, Roy G. Cytokine production by IEL subsets in Celiac Disease. Dig Dis Sci 2005;50:593-600.